Richard Beasley

58.0k total citations · 15 hit papers
596 papers, 34.9k citations indexed

About

Richard Beasley is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Richard Beasley has authored 596 papers receiving a total of 34.9k indexed citations (citations by other indexed papers that have themselves been cited), including 301 papers in Pulmonary and Respiratory Medicine, 300 papers in Physiology and 60 papers in Epidemiology. Recurrent topics in Richard Beasley's work include Asthma and respiratory diseases (291 papers), Respiratory and Cough-Related Research (147 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (101 papers). Richard Beasley is often cited by papers focused on Asthma and respiratory diseases (291 papers), Respiratory and Cough-Related Research (147 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (101 papers). Richard Beasley collaborates with scholars based in New Zealand, United Kingdom and Australia. Richard Beasley's co-authors include Neil Pearce, Mark Weatherall, Julian Crane, Matthew Masoli, Shaun Holt, Denise Fabian, Stephen T. Holgate, Ulrich Keil, Edwin A. Mitchell and Sarah Aldington and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard Beasley

566 papers receiving 33.4k citations

Hit Papers

International Study of As... 1989 2026 2001 2013 1995 1998 2004 1990 2007 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods
    1995 2.9k citations Richard Beasley, Neil Pearce et al. European Respiratory Journal profile →
  2. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC
    1998 2.7k citations Richard Beasley profile →
  3. The global burden of asthma: executive summary of the GINA Dissemination Committee Report
    2004 2.6k citations Richard Beasley et al. profile →
  4. Mucosal Inflammation in Asthma
    1990 1.1k citations Richard Beasley et al. profile →
  5. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)
    2007 914 citations Neil Pearce, Richard Beasley et al. profile →
  6. Cellular Events in the Bronchi in Mild Asthma and after Bronchial Provocation
    1989 903 citations Richard Beasley et al. profile →
  7. SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS
    1989 898 citations Richard Beasley et al. profile →
  8. Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
    2004 839 citations Richard Beasley et al. profile →
  9. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)
    2009 768 citations Richard Beasley et al. profile →
  10. Treatable traits: toward precision medicine of chronic airway diseases
    2016 653 citations Àlvar Agustí, Mike Thomas et al. European Respiratory Journal profile →
  11. Epidemiology and costs of chronic obstructive pulmonary disease
    2005 543 citations P. Vermeire, A. Sonia Buist et al. European Respiratory Journal profile →
  12. PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY
    1989 440 citations Neil Pearce, Richard Beasley et al. profile →
  13. Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit
    2015 414 citations Paul J. Young, Michael Bailey et al. profile →
  14. Risk factors for asthma: is prevention possible?
    2015 366 citations Richard Beasley, Alex Semprini et al. profile →
  15. Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma
    2019 266 citations Richard Beasley, Mark Holliday et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Richard Beasley 21.9k 17.7k 6.0k 2.9k 2.6k 596 34.9k
Scott T. Weiss 22.8k 1.0× 16.2k 0.9× 4.1k 0.7× 3.4k 1.2× 3.0k 1.1× 767 43.3k
Fernando D. Martínez 20.7k 0.9× 16.0k 0.9× 5.4k 0.9× 4.9k 1.7× 4.8k 1.8× 269 31.4k
Dirkje S. Postma 16.6k 0.8× 18.8k 1.1× 2.5k 0.4× 1.6k 0.5× 2.5k 0.9× 592 31.2k
Peter Burney 12.6k 0.6× 11.0k 0.6× 6.5k 1.1× 1.7k 0.6× 1.8k 0.7× 333 26.4k
Paul M. O’Byrne 30.4k 1.4× 22.7k 1.3× 7.6k 1.3× 1.2k 0.4× 2.3k 0.9× 556 38.1k
Klaus F. Rabe 18.2k 0.8× 25.9k 1.5× 2.1k 0.3× 2.2k 0.8× 2.3k 0.9× 585 37.6k
Leonardo M. Fabbri 19.0k 0.9× 27.9k 1.6× 1.5k 0.3× 3.6k 1.2× 3.1k 1.2× 487 39.5k
Romain Pauwels 17.6k 0.8× 18.3k 1.0× 2.9k 0.5× 1.2k 0.4× 1.7k 0.7× 146 26.3k
Peter G. Gibson 29.2k 1.3× 22.0k 1.2× 3.2k 0.5× 6.2k 2.1× 3.7k 1.4× 1.0k 53.2k
Stanley J. Szefler 18.2k 0.8× 14.7k 0.8× 3.1k 0.5× 1.1k 0.4× 1.6k 0.6× 487 23.9k

Countries citing papers authored by Richard Beasley

Since Specialization
Citations

This map shows the geographic impact of Richard Beasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Beasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Beasley more than expected).

Fields of papers citing papers by Richard Beasley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Beasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Beasley. The network helps show where Richard Beasley may publish in the future.

Co-authorship network of co-authors of Richard Beasley

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Beasley. A scholar is included among the top collaborators of Richard Beasley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Beasley. Richard Beasley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papi, Alberto, Richard Beasley, Elliot Israel, et al.. (2024). Albuterol-budesonide rescue reduces progression from asthma deterioration to severe exacerbation. The Journal of Allergy and Clinical Immunology In Practice. 12(10). 2847–2851.
2.
O’Driscoll, B. Ronan, et al.. (2024). Effect of a lower target oxygen saturation range on the risk of hypoxaemia and elevated NEWS2 scores at a university hospital: a retrospective study. BMJ Open Respiratory Research. 11(1). e002019–e002019. 2 indexed citations
3.
Eathorne, Allie, J Noble, Lee Hatter, et al.. (2024). Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand. Respirology. 30(3). 206–216.
4.
Beasley, Richard, Pepa Bruce, Claire Houghton, & Lee Hatter. (2023). The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review. The Journal of Allergy and Clinical Immunology In Practice. 11(3). 762–772.e1. 21 indexed citations
5.
Bruce, Pepa, Lee Hatter, Claire Houghton, et al.. (2023). The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthma. ERJ Open Research. 9(5). 239–2023. 1 indexed citations
6.
Thomas, Mike & Richard Beasley. (2023). The treatable traits approach to adults with obstructive airways disease in primary and secondary care. Respirology. 28(12). 1101–1116. 7 indexed citations
7.
Pickard, Andrew C & Richard Beasley. (2022). Engineering Complicated Systems Still Needs Systems Engineering and Thinking. INCOSE International Symposium. 32(1). 721–736. 1 indexed citations
8.
Kearns, Ciléin, Allie Eathorne, Nethmi Kearns, et al.. (2022). How best to share research with study participants? A randomised crossover trial comparing a comic, lay summary, and scientific abstract. Journal of Visual Communication in Medicine. 45(3). 172–181. 4 indexed citations
9.
Kearns, Nethmi, et al.. (2022). Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: a randomised crossover trial. European Respiratory Journal. 60(3). 2102309–2102309. 4 indexed citations
10.
Beasley, Richard, et al.. (2021). Social Science Solutions for the Systems Engineer: What's Needed. INCOSE International Symposium. 31(1). 699–712. 1 indexed citations
11.
Brown, Simon G.A., Kyle Perrin, Stephen Asha, et al.. (2020). Conservative versus Interventional Treatment for Spontaneous Pneumothorax. New England Journal of Medicine. 382(5). 405–415. 125 indexed citations
12.
McDonald, Vanessa M., James Fingleton, Àlvar Agustí, et al.. (2019). Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. European Respiratory Journal. 53(5). 1802058–1802058. 199 indexed citations
13.
Weinkove, Robert, Catherine Wood, John Carter, et al.. (2019). A randomized controlled feasibility trial of paracetamol during febrile neutropenia in hemato-oncology patients. Leukemia & lymphoma. 60(6). 1540–1547. 3 indexed citations
14.
Young, Paul J., Richard Beasley, Gilles Capellier, Glenn M. Eastwood, & Steve Webb. (2015). Oxygenation targets and monitoring in the critically ill: a point prevalence study of clinical practice in Australia and New Zealand. Critical Care and Resuscitation. 17(3). 202–207.e4. 2 indexed citations
15.
Reddy, Sumeet, Paul J. Young, Richard Beasley, et al.. (2015). Overview of the study protocols and statistical analysis plan for the Saline versus Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program. Critical Care and Resuscitation. 17(1). 29–36.e5. 12 indexed citations
16.
Fingleton, James, Justin Travers, Mathew Williams, et al.. (2015). Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. Journal of Allergy and Clinical Immunology. 136(3). 601–609. 34 indexed citations
17.
Kocks, Janwillem, Mark Weatherall, Esther Metting, et al.. (2014). Phenotyping airways disease by cluster analysis in primary care: 6 distinct clusters identified. European Respiratory Journal. 44(Suppl 58). 1977–1977. 1 indexed citations
18.
Reddy, Sumeet, Michael Bailey, Richard Beasley, et al.. (2014). A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study. Critical Care and Resuscitation. 16(4). 274–279. 15 indexed citations
19.
Young, Paul J., Manoj Saxena, Rinaldo Bellomo, et al.. (2012). The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection. Critical Care and Resuscitation. 14(4). 290–296. 13 indexed citations
20.
Ackermann‐Liebrich, Ursula, H Ross Anderson, Josep M. Antó, et al.. (1999). Asthma mortality:summary of a round-table discussion, New York, January 1997. European Respiratory Journal. 13(1). 221–221. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott T. Weiss Breakdown of academic impact, for papers by Fernando D. Martínez Breakdown of academic impact, for papers by Dirkje S. Postma Breakdown of academic impact, for papers by Peter Burney Breakdown of academic impact, for papers by Paul M. O’Byrne Breakdown of academic impact, for papers by Klaus F. Rabe Breakdown of academic impact, for papers by Leonardo M. Fabbri Breakdown of academic impact, for papers by Romain Pauwels Breakdown of academic impact, for papers by Peter G. Gibson Breakdown of academic impact, for papers by Stanley J. Szefler
Rankless by CCL
2026